カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の内分泌検査市場2023-2030：検査種類別（FSH、インスリン）、技術別（タンデム質量分析、イムノアッセイ）、エンドユーザー別、地域別

【英語タイトル】Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV104）・商品コード：GRV23NOV104
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

内分泌検査市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の内分泌検査市場規模は2030年までに214.2億米ドルに達し、予測期間中のCAGRは8.4%を記録する見込みです。成人だけでなく高齢者人口における肥満や糖尿病、甲状腺などの生活習慣病の有病率の増加が、内分泌検査のニーズを促進しています。個人における定期的な内分泌検査は、全体的な健康維持に役立つため、より良い健康への意識が世界の内分泌検査市場の成長に大きく貢献しています。

WHOの統計によると、2020年には、5歳未満の3,900万人以上の子供たちが太りすぎまたは肥満になっています。座りっぱなしの生活と不健康な食事の選択が、一般人口の肥満や糖尿病の原因となっています。このような疾病の発生は、代謝機能や関連するホルモン障害に関する多くの研究を促しています。

政府や民間団体からの資金援助も科学界を動かしています。例えば、NIHのNIDDK（国立糖尿病・消化器・腎臓病研究所）は、疾患のより良い理解による健康増進を目指し、多くのスポンサー付き研究プログラムを推進しています。NIDDKによるそのような取り組みの1つが、2022年9月に行われた糖尿病と肥満研究のための大西洋中部シンポジウムです。これは科学的知識の交換と交流を可能にし、地域レベルでの協力を可能にします。このような取り組みは、人体における内分泌機能の理解を促進し、内分泌検査市場の成長をさらに可能にするでしょう。

低開発国や発展途上国における認識不足は、内分泌検査市場の成長を鈍らせると予想されます。発展途上の医療環境と償還モデルの不在が、これらの地域の個人が定期的な内分泌検査を受けることを抑制しています。しかし、COVID-19の大流行時に健康なシステムに対する意識が高まったことで、これらの国々でも検査頻度が上昇すると予想されます。

COVID-19の流行は、内分泌検査の応用に有利な機会を生み出しました。COVID-19感染は、多くの臓器を傷害する全身性疾患を引き起こします。そのため、これらの患者には多くの代謝障害やホルモン障害があり、内分泌研究の増加につながりました。例えば、2021年3月、内分泌学会の会員は、内分泌系に対するCOVID-19の短期および長期の影響を特定し、理解するためのCOVID-19研究を支援するために100億米ドルを承認しました。同様に、2020年9月、米国糖尿病協会は、糖尿病とCOVID-19の関連を調査するためのさまざまな研究プロジェクトに100万米ドルを投資しました。したがって、需要が増加し、市場の成長をさらに後押しするでしょう。

さらに、監禁による移動の制限や制約が、医療相談や自宅でのサンプル採取サービスのためのデジタル・プラットフォームを後押ししました。自宅でホルモン値を検出するためのポイントオブケア機器やキットの入手可能性も、内分泌検査市場全体の成長を後押ししています。

また、内分泌検査市場の成長が期待されるさまざまな要因によって、市場プレーヤーは地域プレゼンスを拡大しています。コラボレーション、パートナーシップ、グローバル展開は、収益創出を促進するための主要プレーヤーによる事業戦略の一部です。例えば、2022年2月、Laboratory Corporation of America Holdings（Labcorp）は、米国インディアナ州に新たなラボを開設すると発表しました。インディアナ州サウスベンドにおける新たな診断事業は、同社のサービスを強化し、この地域の患者だけでなく医師にとっても利用しやすいものとなるでしょう。

内分泌検査市場レポートハイライト

- 検査タイプ別では、ヒト絨毛性ゴナドトロピン（hCG）ホルモン検査が2022年に最も大きなシェアを占めました。さらに、妊娠週数の違いによる検査頻度の違いや、妊娠可能な女性人口の多さも一因となっています。

- 技術別では、イムノアッセイが2022年市場を支配しました。これは、イムノアッセイに基づく検出技術を使用する主要企業による機器の存在によるものです。イムノアッセイ技術に依存する多くの機器と検査パネルが内分泌検査市場の成長を牽引しました。

- エンドユーザー別では、商業検査室が2022年の売上高に大きく貢献しました。内分泌学と生殖機能のための多様な検査パネルの実現可能性と利用可能性、自宅採取のようなサービス、デジタルプラットフォームの存在が、セグメントシェアの拡大につながりました。

- 2022年に内分泌検査市場で最も収益が高かったのは北米でした。これは、米国人口に甲状腺疾患、糖尿病、肥満が多いためです。さらに、この地域では医療が発達し、支出パターンが増加していることも、収益増につながりました。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の内分泌検査市場変数・傾向・範囲
第4章 世界の内分泌検査市場：検査種類別予測・傾向分析
第5章 世界の内分泌検査市場：技術別予測・傾向分析
第6章 世界の内分泌検査市場：エンドユーザー別予測・傾向分析
第7章 世界の内分泌検査市場：地域別予測・傾向分析
第8章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Technology
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. Technology outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Endocrine Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Endocrine Testing Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Endocrine Testing: Test Type Estimates & Trend Analysis
4.1. Endocrine Testing Market: Key Takeaways
4.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Estradiol (E2) Test
4.3.1. Estradiol (E2) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Follicle Stimulating Hormone (FSH) Test
4.4.1. Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Human Chorionic Gonadotropin (hCG) Hormone Test
4.5.1. Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Luteinizing Hormone (LH) Test
4.6.1. Luteinizing Hormone (LH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Dehydroepiandrosterone Sulfate (DHEAS) Test
4.7.1. Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Progesterone Test
4.8.1. Progesterone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Testosterone Test
4.9.1. Testosterone test market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Thyroid Stimulating Hormone (TSH) Test
4.10.1. Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Prolactin Test
4.11.1. Prolactin test market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Cortisol Test
4.12.1. Cortisol test market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Insulin Test
4.13.1. Insulin test market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Others
4.14.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Endocrine Testing: Technology Estimates & Trend Analysis
5.1. Endocrine Testing Market: Key Takeaways
5.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Tandem Mass Spectrometry
5.3.1. Tandem mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Immunoassay
5.4.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Monoclonal & Polyclonal Antibody Technologies
5.5.1. Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Sensor Technology
5.6.1. Sensor technology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Clinical Chemistry
5.7.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Endocrine Testing: End-use Estimates & Trend Analysis
6.1. Endocrine Testing Market: Key Takeaways
6.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Commercial Laboratories
6.4.1. Commercial laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Care Centers
6.5.1. Ambulatory care centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Endocrine Testing Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Abbott Laboratories
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. AB Sciex
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Agilent Technologies Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. bioMerieux SA
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Bio-Rad Laboratories Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. DiaSorin S.p.A.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. F. Hoffmann-La Roche Ltd.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Laboratory Corporation of America Holdings
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Quest Diagnostics Incorporated
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Ortho Clinical Diagnostics
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 3 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 4 North America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 13 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 14 Europe endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 16 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 20 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 21 UK endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 22 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 23 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 24 France endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 32 Sweden endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 33 Sweden endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Norway endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 35 Norway endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 36 Norway endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 37 Denmark endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 38 Denmark endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 39 Denmark endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 42 Asia Pacific endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 44 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 45 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 46 China endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 50 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 51 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 52 India endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 54 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 55 Australia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 56 Thailand endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 57 Thailand endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 58 Thailand endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 60 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 61 South Korea endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 63 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 64 Latin America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Latin America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 67 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 70 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 73 Argentina endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 80 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 86 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 89 Kuwait endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait endocrine testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Endocrine testing: Market outlook
Fig. 9 Endocrine testing: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Endocrine testing market driver impact
Fig. 15 Endocrine testing market restraint impact
Fig. 16 Endocrine testing market strategic initiatives analysis
Fig. 17 Endocrine testing market: Test type movement analysis
Fig. 18 Endocrine testing market: Test type outlook and key takeaways
Fig. 19 Estradiol (E2) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Luteinizing Hormone (LH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Progesterone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Testosterone test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Prolactin test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Cortisol test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Insulin test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Endocrine testing market: Technology movement analysis
Fig. 32 Endocrine testing market: Technology outlook and key takeaways
Fig. 33 Tandem mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Sensor technology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Endocrine testing market: End-use movement analysis
Fig. 40 Endocrine testing market: End-use outlook and key takeaways
Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Commercial laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Ambulatory care centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Global endocrine testing market: Regional movement analysis
Fig. 46 Global endocrine testing market: Regional outlook and key takeaways
Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の内分泌検査市場2023-2030：検査種類別（FSH、インスリン）、技術別（タンデム質量分析、イムノアッセイ）、エンドユーザー別、地域別] (コード：GRV23NOV104)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の内分泌検査市場2023-2030：検査種類別（FSH、インスリン）、技術別（タンデム質量分析、イムノアッセイ）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別
  • 世界の内分泌検査市場予測2023年-2028年：検査タイプ別（甲状腺検査、インスリン検査、ヒト絨毛性ゴナドトロピン検査、プロラクチン検査、黄体形成ホルモン検査、プロゲステロン検査、その他）、技術別（イムノアッセイ、タンデム質量分析、センサー技術、LC-MS、その他）、エンドユーザー別（病院、外来ケアセンター、臨床検査室、その他）、地域別
  • 世界の心不全用POC・LOC機器市場2023-2030：検査種類別、技術別（マイクロ流体、アレイベースシステム）、エンドユーザー別（診療所、病院、生活支援医療施設）、地域別
  • 世界の医薬品無菌性試験市場（2023-2030）：製品種類別（装置、サービス）、種類別（アウトソーシング、インハウス）、検査種類別、サンプル別、エンドユーザー別、地域別
  • 世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別
  • 世界の子宮頸がん診断市場2023-2030：検査種類別（パップテスト/細胞診検査、HPV検査、コルポスコピー、子宮頸部生検）、年齢層別、エンドユーザー別、地域別
  • 世界のHIV診断市場2023-2030：製品別（消耗品、機器）、検査種類別（抗体検査、ウイルス負荷検査）、モード別（自己検査、研究所ベース）、エンドユーザー別、地域別
  • 世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別
  • 世界のラテラルフローアッセイ市場2023-2030：製品別（キット・試薬）、用途別（臨床検査）、技術別、検査種類別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆